1 – 10 of 35
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
A Gradual Transition Toward Anaplasia in Wilms Tumor Through Tolerance to Genetic Damage
2024) In Modern Pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 37(1). p.100382-100382(
- Contribution to journal › Article
-
Mark
Antihypertensive drug targets and breast cancer risk : a two-sample Mendelian randomization study
2024) In European Journal of Epidemiology(
- Contribution to journal › Article
-
Mark
Haplotype analysis identifies functional elements in monoclonal gammopathy of unknown significance
(
- Contribution to journal › Article
-
Mark
Weaponized genomics : potential threats to international and human security
(
- Contribution to journal › Letter
- 2023
-
Mark
Modelling evolution at the boundaries of solid tumours
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Resolving the Pathogenesis of Anaplastic Wilms Tumors through Spatial Mapping of Cancer Cell Evolution
(
- Contribution to journal › Article
-
Mark
Weaponized Genomics: New Threats to International Security and Human Rights
2023) In Nature Reviews. Genetics(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Germline variants of the genes involved in NF-kB activation are associated with the risk of COPD and lung cancer development
(
- Contribution to journal › Article
- 2022
-
Mark
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6
(
- Contribution to journal › Letter
-
Mark
Branching copy number evolution and parallel immune profiles across the regional tumor space of resected pancreatic cancer
(
- Contribution to journal › Article